Merck KGaA on Thursday forecast currency-adjusted operating earnings growth of up to 8%, helped by demand for semiconductor ...

European discounter Pepco Group said on Thursday it was evaluating all strategic options to separate its struggling 825-store ...

Wiley (NYSE: WLY), one of the world's largest publishers and a trusted leader in research and learning, today announced the appointment of Karen N. Madden, Ph.D., to its Board of Directors. Madden is ...

MilliporeSigma Chief Technology Officer Brings Extensive Science, Technology, and Innovation Leadership Experience Wiley (NYSE: WLY), one of the world's largest publishers and a trusted leader in ...

The risk premia, or credit spreads, on euro bank bonds is widening due to increased market volatility, ABN Amro's Joost Beaumont said. "We expect spreads to continue to widen in the coming week, while ...

Also in today’s newsletter, US government spending on consultants and Trump hands carmakers reprieve from tariffs ...

Victoria's Secret & Co. on Wednesday said it expects the year ahead to "gradually get better," despite what it characterized as shaky consumer confidence and sales forecasts that came in below ...

Don't discount the power of momentum. Some studies have found that momentum trading -- buying stocks or exchange-traded funds ...

The increasing occurrence of chronic and infectious diseases is the main driver of the rising demand for interferon. Furthermore, advancements in interferon production and ongoing research and ...

The latest pharma company to make a move for an mRNA specialist is Germany's ... of the pillars of Merck's business, delivered via its process solutions unit, part of the group's life sciences ...

Just 2% of patients on MK-0616 discontinued treatment due to adverse events, compared to 1% of the placebo group. A key advantage for Merck’s drug is that it could slot into therapy alongside ...